Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the PK and PD of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis

NCT00488839 is registered in ClinicalTrials.gov with Impax Laboratories, LLC as lead sponsor.

NCT NCT00488839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00488839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the PK and PD of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Lead sponsor
Impax Laboratories, LLC
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2007
Completion date
May 31, 2008
Enrollment
173 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis